DHILLON AVTAR S 4
4 · INOVIO PHARMACEUTICALS, INC. · Filed Dec 6, 2018
Insider Transaction Report
Form 4
DHILLON AVTAR S
DirectorExecutive Chairman
Transactions
- Exercise/Conversion
Common Stock
2018-12-06$2.00/sh+25,000$50,000→ 106,002 total - Exercise/Conversion
Common Stock Options
2018-12-06−25,000→ 0 totalExercise: $2.00From: 2008-12-09Exp: 2018-12-09→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014.
- [F2]The shares underlying this option vested and became exercisable on various dates between December 9, 2008 and December 9, 2011.